In an Ontario study (2011–2019) of people with invasive pneumococcal disease:*
cases among adults 50-64 resulted in death out of 2,957 cases
cases among adults 65+ resulted in death out of 4,595 cases
CAPVAXIVE® will not protect against complications such as hospitalization or death, but it may help protect those at risk against invasive pneumococcal disease.
Age
matters
50 or older?
Your chance of getting invasive pneumococcal disease is higher than when you were younger.
Your
next move?
Ask your doctor or pharmacist about getting vaccinated with CAPVAXIVE®.
CAPVAXIVE® is publicly covered in certain provinces!
Public funding is available for residents of Quebec and Saskatchewan.
Ask a healthcare professional about coverage in your province.
CAPVAXIVE® is a vaccine for adults 18 years of age and older to help protect against invasive pneumococcal disease caused by bacteria called pneumococcus. These bacteria can cause many types of illnesses, which can be invasive (severe), such as infections in:
- your lungs (called bacteremic pneumonia)
- the area around the brain and spinal cord (called meningitis)
- your blood (called bacteremia)
Check your invasive pneumococcal disease risk now
Take this quiz to see if you’re at a higher risk.
Start a discussion with your healthcare professional about CAPVAXIVE®
Where can I get vaccinated with CAPVAXIVE®?
Ask a healthcare professional where you can get vaccinated.
You can also use the vaccination site locator below to find CAPVAXIVE® at a clinic or pharmacy close by.
Locate a vaccination site near you